Squo solves risky research
Kaiser 22 [ Jocelyn Kaiser, staff writer for Science magazine, 3-1-2022, “Spurred by Pandemic, U.S. government will revisit federal policies on risky virus research”, Science, https://www.science.org/content/article/spurred-pandemic-u-s-government-will-revisit-federal-policies-risky-virus-research, accessed 6-28-2022]
In the wake of the coronavirus pandemic, the U.S. government is revisiting its oversight of experiments that involve modifying pathogens in ways that might make them more harmful to people. Yesterday, White House officials and the National Institutes of Health (NIH) asked an expert advisory board to undertake a swift, broad review of the agency’s policies that aim to make sure federally funded studies of viruses and other microbes that could cause a pandemic are undertaken safely, and to bar funding for experiments deemed too risky.
The review—to be conducted over 10 months by the National Science Advisory Board for Biosecurity (NSABB)—could include consideration of whether controversial coronavirus experiments funded by the United States in China should have received stricter scrutiny. The panel might also explore whether the United States should fund any such pathogen research conducted abroad, where NIH may have less ability to enforce its rules.
Researchers who say federal oversight of potentially risky research is too lax are welcoming the review. But some NSABB members and outside scientists worry it could result in recommendations that limit U.S. support for research essential to fighting SARS-CoV-2 and future pandemics.
The goal of the biosecurity policy review is to examine some “challenging questions, including … whether there are some experiments that should not be done because of the risks they pose,” said Daniel Gastfriend, director for biodefense and pandemic preparedness at the White House’s National Security Council, during the online NSABB meeting yesterday.
Some researchers have long worried that pathogens being studied in labs could accidentally escape, or even be deliberately released. They have become particularly concerned about certain gain-of-function (GOF) experiments in which researchers give pathogens new capabilities, such as the ability to spread among mammals, in order to better understand their biology.
In response to such concerns, the U.S. government over the past decade has developed several regulatory systems that impose stricter oversight on research involving especially problematic human and animal pathogens. One set of rules, for example, requires NIH to impose special requirements on studies that involve what NIH defines as enhanced potential pandemic pathogens (ePPPs).